Ardent Health, Inc.
ARDT
$9.23
$0.020.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.72% | 6.01% | 10.86% | 10.03% | 8.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.72% | 6.01% | 10.86% | 10.03% | 8.91% |
| Cost of Revenue | 3.52% | 4.85% | 7.32% | 7.35% | 6.52% |
| Gross Profit | 9.10% | 6.86% | 13.58% | 12.07% | 10.75% |
| SG&A Expenses | 7.48% | 6.50% | 6.67% | 5.77% | 6.05% |
| Depreciation & Amortization | 10.43% | 6.44% | 5.61% | 4.89% | 3.99% |
| Other Operating Expenses | 34.95% | 30.45% | 36.59% | 17.40% | 8.63% |
| Total Operating Expenses | 8.22% | 7.89% | 9.49% | 7.49% | 6.44% |
| Operating Income | -14.51% | -19.76% | 37.91% | 60.71% | 62.26% |
| Income Before Tax | -24.68% | -21.13% | 76.52% | 117.27% | 112.47% |
| Income Tax Expenses | -15.88% | -11.25% | 83.97% | 152.68% | 141.27% |
| Earnings from Continuing Operations | -26.59% | -23.21% | 74.98% | 110.45% | 107.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -8.21% | -5.55% | -18.16% | -14.39% | -18.73% |
| Net Income | -40.24% | -35.43% | 122.92% | 194.63% | 192.52% |
| EBIT | -14.51% | -19.76% | 37.91% | 60.71% | 62.26% |
| EBITDA | -7.77% | -12.82% | 26.77% | 41.32% | 40.91% |
| EPS Basic | -41.93% | -38.06% | 105.49% | 165.74% | 169.59% |
| Normalized Basic EPS | -29.96% | -41.26% | 104.13% | 194.59% | 258.06% |
| EPS Diluted | -41.71% | -38.22% | 103.50% | 163.35% | 166.90% |
| Normalized Diluted EPS | -30.24% | -41.59% | 102.75% | 192.77% | 256.70% |
| Average Basic Shares Outstanding | 3.85% | 6.35% | 8.97% | 10.53% | 7.70% |
| Average Diluted Shares Outstanding | 3.93% | 6.59% | 9.38% | 11.13% | 8.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |